Cargando…

Subgroup identification for treatment selection in biomarker adaptive design

BACKGROUND: Advances in molecular technology have shifted new drug development toward targeted therapy for treatments expected to benefit subpopulations of patients. Adaptive signature design (ASD) has been proposed to identify the most suitable target patient subgroup to enhance efficacy of treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Tzu-Pin, Chen, James J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673750/
https://www.ncbi.nlm.nih.gov/pubmed/26646831
http://dx.doi.org/10.1186/s12874-015-0098-7

Ejemplares similares